National Health Investors (NYSE:NHI) Reaches New 52-Week High at $68.28

National Health Investors, Inc. (NYSE:NHI) reached a new 52-week high during trading on Tuesday . The company traded as high as $68.28 and last traded at $67.98, with a volume of 22297 shares trading hands. The stock had previously closed at $67.53.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on NHI. StockNews.com lowered shares of National Health Investors from a “buy” rating to a “hold” rating in a research note on Thursday, April 18th. Truist Financial increased their target price on National Health Investors from $58.00 to $65.00 and gave the stock a “hold” rating in a report on Wednesday, June 26th. Wedbush boosted their price target on National Health Investors from $64.00 to $66.00 and gave the company an “outperform” rating in a report on Monday, March 18th. BMO Capital Markets raised National Health Investors from a “market perform” rating to an “outperform” rating and set a $67.00 price target on the stock in a research report on Tuesday, March 12th. Finally, Wells Fargo & Company lifted their price objective on shares of National Health Investors from $63.00 to $69.00 and gave the stock an “overweight” rating in a report on Thursday, May 30th. Five research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $62.13.

National Health Investors Price Performance

The company has a market capitalization of $2.98 billion, a P/E ratio of 22.48 and a beta of 1.02. The company has a quick ratio of 13.24, a current ratio of 13.24 and a debt-to-equity ratio of 0.91. The business has a 50 day simple moving average of $65.82 and a 200-day simple moving average of $60.25.

National Health Investors Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 2nd. Investors of record on Friday, June 28th will be issued a $0.90 dividend. The ex-dividend date of this dividend is Friday, June 28th. This represents a $3.60 dividend on an annualized basis and a dividend yield of 5.25%. National Health Investors’s dividend payout ratio (DPR) is presently 118.03%.

Insider Buying and Selling at National Health Investors

In other news, Director Robert A. Mccabe, Jr. purchased 437 shares of the company’s stock in a transaction on Friday, May 31st. The shares were bought at an average price of $65.83 per share, for a total transaction of $28,767.71. Following the completion of the purchase, the director now owns 21,585 shares of the company’s stock, valued at $1,420,940.55. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 8.21% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the business. Lasalle Investment Management Securities LLC lifted its holdings in National Health Investors by 8.4% in the first quarter. Lasalle Investment Management Securities LLC now owns 508,035 shares of the real estate investment trust’s stock worth $31,920,000 after purchasing an additional 39,554 shares during the period. Tidal Investments LLC raised its position in shares of National Health Investors by 22.4% during the 1st quarter. Tidal Investments LLC now owns 4,701 shares of the real estate investment trust’s stock worth $291,000 after buying an additional 861 shares in the last quarter. Benchmark Investment Advisors LLC acquired a new stake in shares of National Health Investors in the 1st quarter worth approximately $314,000. Price T Rowe Associates Inc. MD boosted its holdings in shares of National Health Investors by 6.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 26,836 shares of the real estate investment trust’s stock valued at $1,687,000 after acquiring an additional 1,516 shares in the last quarter. Finally, CANADA LIFE ASSURANCE Co increased its stake in shares of National Health Investors by 2.3% during the first quarter. CANADA LIFE ASSURANCE Co now owns 55,985 shares of the real estate investment trust’s stock valued at $3,518,000 after acquiring an additional 1,248 shares during the period. Institutional investors own 62.51% of the company’s stock.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.